Divrik Rauf Taner, Sahin Ali, Altok Muammer, Unlü Nuri, Zorlu Ferruh
Department of Urology, SB Tepecik Research and Training Hospital, Izmir, Turkey.
J Urol. 2007 Sep;178(3 Pt 1):802-6; discussion 806. doi: 10.1016/j.juro.2007.05.054. Epub 2007 Jul 16.
We determined the frequency of hydronephrosis at initial diagnosis, and its effect on recurrence and progression in patients with superficial bladder cancer.
Between January 1993 and April 2006 we retrospectively reviewed the records of 931 patients with superficial transitional cell carcinoma of the bladder at our institute. Hydronephrosis status was determined by excretory urogram, ultrasound or computerized tomography of the abdomen and pelvis at initial evaluation. The number of tumors, tumor size, tumor location, T category (pTa vs pT1) and histological grade were assessed at study entry. The absence or presence of unilateral or bilateral upper tract obstruction/hydronephrosis was recorded for all cohorts. We examined the frequency of hydronephrosis in patients with superficial bladder carcinoma according to T status and investigated the relationship between hydronephrosis, and recurrence-free and progression-free survival for pTa and pT1 stage. The end points assessed were recurrence and progression.
Histopathological results showed that 63.8% of all superficial bladder cancer cases were pT1 stage. Preoperative radiological evaluation revealed unilateral and bilateral hydronephrosis in 70 (7.5%) and 19 (2.1%) patients in all cohorts, respectively. Of patients with pTa tumors 304 (90.2%) had low grade lesions and 207 (61.4%) had a single tumor. Unilateral and bilateral hydronephrosis was detected in 16 (4.7%) and 4 (1.2%) patients with pTa, respectively. Of patients with pT1 tumors 196 (33.0%) had low grade lesions and 283 (47.6%) had a single tumor. Unilateral and bilateral hydronephrosis was detected in 54 (9.1%) and 15 (2.5%) patients with pT1 disease, respectively. The increased probability of hydronephrosis was detected in higher stage, higher grade multiple tumors and in tumors larger than 3 cm. Of 931 patients 37.9% had at least 1 recurrence with an incidence of 27.3% for Ta and 43.9% for T1 disease. The recurrence rate was 52.8% for patients with hydronephrosis, that is 35.0% for Ta and 58.0% for T1 disease. Median time to first recurrence was 22 months. Multivariate Cox analysis confirmed that T category, grade, tumor size and hydronephrosis were significant prognostic variables of recurrence. Of the cases 11% progressed to muscle invasive bladder cancer. Multivariate analysis revealed that progression was statistically significant for T category, disease grade, multiplicity, tumor size and the presence or absence of hydronephrosis.
Unilateral/bilateral hydronephrosis detected at the first evaluation at diagnosis of superficial bladder tumors is an independent prognostic factor for recurrence and progression.
我们确定了初诊时肾盂积水的发生率及其对浅表性膀胱癌患者复发和进展的影响。
1993年1月至2006年4月期间,我们回顾性分析了我院931例浅表性膀胱移行细胞癌患者的病历。在初始评估时,通过排泄性尿路造影、超声或腹部及盆腔计算机断层扫描确定肾盂积水情况。在研究开始时评估肿瘤数量、肿瘤大小、肿瘤位置、T分期(pTa与pT1)和组织学分级。记录所有队列中单侧或双侧上尿路梗阻/肾盂积水的有无。我们根据T分期检查了浅表性膀胱癌患者中肾盂积水的发生率,并研究了肾盂积水与pTa和pT1期患者无复发生存率及无进展生存率之间的关系。评估的终点为复发和进展。
组织病理学结果显示,所有浅表性膀胱癌病例中63.8%为pT1期。术前影像学评估显示,所有队列中分别有70例(7.5%)和19例(2.1%)患者存在单侧和双侧肾盂积水。在pTa肿瘤患者中,304例(90.2%)为低级别病变,207例(61.4%)为单发肿瘤。pTa患者中分别有16例(4.7%)和4例(1.2%)检测到单侧和双侧肾盂积水。在pT1肿瘤患者中,196例(33.0%)为低级别病变,283例(47.6%)为单发肿瘤。pT1期患者中分别有54例(9.1%)和15例(2.5%)检测到单侧和双侧肾盂积水。在更高分期、更高级别多发肿瘤以及大于3 cm的肿瘤中,肾盂积水的发生率增加。931例患者中,37.9%至少有1次复发,Ta期复发率为27.3%,T1期为43.9%。肾盂积水患者的复发率为52.8%,即Ta期为35.0%,T1期为58.0%。首次复发的中位时间为22个月。多因素Cox分析证实,T分期、分级、肿瘤大小和肾盂积水是复发的重要预后变量。11%的病例进展为肌层浸润性膀胱癌。多因素分析显示,T分期、疾病分级、肿瘤数量、肿瘤大小以及肾盂积水的有无对进展具有统计学意义。
在浅表性膀胱肿瘤诊断时首次评估发现的单侧/双侧肾盂积水是复发和进展的独立预后因素。